跳至主要内容
临床试验/NCT00598728
NCT00598728已完成不适用

A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 255 人开始时间: 2005年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
255
试验地点
1
主要终点
To evaluate the prevalence of late medical complications among HL survivors

研究概览

简要总结

The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Biopsy-proven HL Participation in IRB-approved protocols for the first-line treatment of HL between 1975-2000 (IRB #75-104, #75-103, #79-17, #81-103, #90-44, #91-69).
  • English speaking

排除标准

  • 未提供

结局指标

主要结局

To evaluate the prevalence of late medical complications among HL survivors

时间窗: conclusion of study

次要结局

  • To study the effect of HL and its treatment on QOL among HL survivors.(conclusion of study)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验